Who invested in Character Biosciences?
Character Biosciences's investors include Catalio Capital Management, S32, aMoon, Luma Group and Innovation Endeavors, and 6 more on record.

United States · Series B startup
Funding summaryUpdated 26 Oct 2026
$110Mraised across 2 rounds since 2025, from 2 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
Source recordedSEC filing: $8.9M sold, first sale Sept 2025
Reported by Jefferson Life SciencesSEC filing: $8.9M sold, first sale Sept 2025
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Character Biosciences's investors include Catalio Capital Management, S32, aMoon, Luma Group and Innovation Endeavors, and 6 more on record.
Character Biosciences has raised $110M across 2 rounds since 2025.
Character Biosciences's most recent round was a Series B of $17M in Sept 2025.
Character Biosciences's largest round on record is $93M (Series B), in Jul 2025, led by aMoon.
Character Biosciences's first round on record, in Jul 2025, was backed by aMoon, Luma Group and Innovation Endeavors and 5 others.
Character Biosciences's latest named round is a Series B, in Sept 2025.
Character Biosciences is based in the United States.
aMoon led the Series B in 2025.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.